Wells Fargo’s enVVeno Medical NVNO Stock Holding History

Wells Fargo’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16K	Buy	114 +57	+100%	+$624	﹤0.01%	6322
2025 Q4	$642	Hold	57	–	–	﹤0.01%	6315
2025 Q3	$1.81K	Hold	57	–	–	﹤0.01%	6195
2025 Q2	$7.98K	Hold	57	–	–	﹤0.01%	6003
2025 Q1	$5.26K	Hold	57	–	–	﹤0.01%	6015
2024 Q4	$6.04K	Hold	57	–	–	﹤0.01%	6031
2024 Q3	$6.72K	Hold	57	–	–	﹤0.01%	5870
2024 Q2	$10.5K	Sell	57 -3	-5%	-$524	﹤0.01%	5728
2024 Q1	$11.4K	Hold	60	–	–	﹤0.01%	5728
2023 Q4	$10.8K	Buy	60 +1	+2%	+$159	﹤0.01%	5823
2023 Q3	$11.1K	Hold	59	–	–	﹤0.01%	5783
2023 Q2	$6.35K	Hold	59	–	–	﹤0.01%	6033
2023 Q1	$9.64K	Hold	59	–	–	﹤0.01%	5871
2022 Q4	$10.5K	Hold	59	–	–	﹤0.01%	5534
2022 Q3	$13K	Hold	59	–	–	﹤0.01%	5586
2022 Q2	$8K	Buy	59 +1	+2%	+$155	﹤0.01%	5846
2022 Q1	$13K	Hold	58	–	–	﹤0.01%	6177
2021 Q4	$13K	Buy	58 +28	+93%	+$7.88K	﹤0.01%	6459
2021 Q3	$10K	Hold	30	–	–	﹤0.01%	6204
2021 Q2	$7K	Buy	30 +29	+2,900%	+$6.23K	﹤0.01%	6243
2021 Q1	$0	Buy	+1	New	+$278	﹤0.01%	7222
2020 Q4	–	Hold	0	–	–	–	6842
2020 Q3	–	Hold	0	–	–	–	6715
2020 Q2	–	Hold	0	–	–	–	6648
2020 Q1	–	Hold	0	–	–	–	6605

Other funds holding NVNO

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's NVNO Position: Q1 2026 in Review

Wells Fargo increased its enVVeno Medical (NVNO) stake by 100% in Q1 2026, buying an estimated $624 and bringing the position to 114 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #6322.

Wells Fargo first reported a position in NVNO in Q1 2021 and has held it in 21 quarters since. The position peaked at $13K in Q3 2022. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

Wells Fargo held 114 shares of enVVeno Medical worth $1.16K as of Q1 2026.
Wells Fargo bought 57 enVVeno Medical shares in Q1 2026, an estimated $624.
enVVeno Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6322 holding.
Wells Fargo first reported a position in enVVeno Medical in Q1 2021 and has held it in 21 quarters since.
Wells Fargo's enVVeno Medical position peaked at $13K in Q3 2022.
17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.